阿尔卡A/TPX2过度表达对染色体失衡和癌症的贡献
Federica Polverino1, Anna Mastrangelo1, Giulia Guarguaglini1
1Institute of Molecular Biology and Pathology, National Research Council of Italy, c/o Sapienza University of Rome, Via degli Apuli 4, 00185 Rome, Italy.
Cells
|August 28, 2024
概括
极光激酶A (AurkA) 和TPX2蛋白过度表达通过促进染色体不稳定性,驱动癌症的进展和治疗耐药性. 准AurkA/TPX2复合体为癌症治疗提供了一个有前途的新疗法策略.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 癌症遗传学 癌症遗传学
背景情况:
- 极光激酶A (AurkA) 和TPX2对于细胞分裂至关重要,它们调节了线粒体的进入,螺旋组合和染色体分离.
- 在各种癌症中,AurkA和TPX2都经常过度表达,这与高增殖率和血管积分相关.
- 以前的研究经常单独研究AurkA和TPX2,尽管它们在瘤中经常同时出现.
研究的目的:
- 对AurkA,TPX2及其复合体在瘤发生中的作用进行现有文献的审查和综合.
- 阐明AurkA/TPX2过度表达的致癌潜力,特别是在诱导染色体不稳定方面.
- 讨论AurkA/TPX2复合体作为癌症治疗的潜在治疗标.
主要方法:
- 文献综述和对AurkA,TPX2及其在癌症中的综合作用的研究综合.
- 分析与AurkA,TPX2或两者的过度表达相关的线粒体表型.
- 讨论奥尔卡/TPX2复合体对癌症发展和抗性的影响.
主要成果:
- 过度表达AurkA,TPX2或它们的复合体导致异常的线粒体表型和染色体不稳定.
- 阿尔卡/TPX2复合体作为癌症进展中的显著瘤原体单位.
- 艾尔卡和TPX2的联合过度表达与瘤的攻击性和治疗耐药性的增加有关.
结论:
- 艾尔卡/TPX2复合体在推动癌症的发展和通过染色体不稳定性的抗性方面发挥着关键作用.
- 针对AurkA/TPX2复合体的破坏是癌症干预的有希望的治疗途径.
- 对AurkA/TPX2复合物的进一步研究是有必要的,以开发有效的癌症疗法.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Nondisjunction
3.8K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.8K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


